Hyattsville, Maryland Clinical Trials

A listing of Hyattsville, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 132 clinical trials
HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma

Gene transfer is a new cancer therapy takes white blood cells from a person and grows them in a lab. The cells are changed with a virus to attack tumor cells, then returned to the person. Researchers want to see if this therapy fights kidney cancer cells. Metastatic renal cell …

clear cell carcinoma
primary cancer
metastatic cancer
clear cell renal cell carcinoma
National Heart, Lung, and Blood Institute (NHLBI)
 (9.7 away) Contact site
  • 22 Dec, 2020
  • 1 location
Caregiver-Provided Life Review for Persons with Dementia in Care Facilities

Five percent of community‐dwelling older Americans experience depression. The rate is higher among persons with dementia (30%). One in 10 older adults (5.6 million) had Alzheimer’s dementia in 2019 and 70% are cared for by their families. This public health issue will worsen as the aging baby boomers grow from …

 (3.6 away) Contact site
  • 07 Jul, 2021
  • +252 other locations
A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma

The purpose of this study is to evaluate MEDI5752 in combination with Lenvatinib (or Axitinib), in subjects with advanced renal cell carcinoma.

Research Site
 (7.8 away) Contact site
  • 03 Sep, 2021
  • +17 other locations
Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)

This study will assess safety and treatment activity of datopotamab deruxtecan (Dato-DXd) in combination with pembrolizumab with or without platinum chemotherapy in participants with advanced or metastatic non-small cell lung cancer.

Johns Hopkins Kimmel Cancer Center
 (8.1 away) Contact site
  • 11 Sep, 2021
  • +23 other locations
Nicotinic Receptor Genetic Variation and Alcohol Reward

Background People with the brain disease AUD (alcohol use disorder) have a serious problem with drinking. Researchers want to study how different people react to alcohol, and how genes affect this. They will focus on a nicotine receptor gene that may increase a person s AUD risk. Objectives To see …

National Institutes of Health Clinical Center
 (9.4 away) Contact site
  • 15 Sep, 2021
  • 1 location
Title: Moxetumomab Pasudotox-tdfk (Lumoxiti ) and Rituximab (Rituxan ) for Relapsed Hairy Cell Leukemia

Background Hairy cell leukemia (HCL) is a rare, slow-growing blood cancer in which the bone marrow makes too many of certain white blood cells. The antibody Rituximab binds to a protein in cancerous white blood cells and is often used to treat HCL. Researchers want to see if combining it …

National Institutes of Health Clinical Center
 (9.7 away) Contact site
  • 12 Sep, 2021
  • 1 location
Safety and Immunogenicity of mRNA-1653 a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine in Healthy Adults and Children 12 to 59 Months of Age With Serologic Evidence of Prior Exposure

This clinical study will assess the safety and immunogenicity of 2 dose levels of mRNA-1653, a combined human metapneumovirus and human parainfluenza virus type 3 vaccine, in healthy adults (18 to 49 years of age) and 3 dose levels in children (12 to 59 months of age) with serologic evidence …

Meridian Clinical Research
 (8.1 away) Contact site
  • 05 Sep, 2021
  • +20 other locations
Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)

Background People with Idiopathic CD4 lymphopenia (ICL) have lower numbers of a type of white blood cell called CD4 cells. White blood cells fight against infections. Low levels of CD4 cells may make a person more likely to get sick. There are no approved treatments for ICL. Researchers think a …

National Institutes of Health Clinical Center
 (9.7 away) Contact site
  • 01 Sep, 2021
  • 1 location
DAY101 In Gliomas and Other Tumors

This research study is studying a drug DAY101 (formerly TAK-580, MLN2480) as a possible treatment a low-grade glioma that has not responded to other treatments. The name of the study drug involved in this study is: DAY101 (formerly TAK-580, MLN2480)

measurable disease
ejection fraction
Children's National Hospital
 (5.3 away) Contact site
  • 30 Aug, 2021
  • +14 other locations
Genomic Responses of Human Immune and Non-Immune Cells to Glucocorticoids

Background The immune system defends the body against bacteria and other harmful invaders. But it can overact and attack healthy cells by mistake. The group of drugs called glucocorticoids (GCs) can calm down an overactive immune system. But they often cause negative side effects. Researchers want to learn how human …

National Institutes of Health Clinical Center
 (9.7 away) Contact site
  • 29 Apr, 2021
  • 1 location